Skip to content

13F-HR filed by SR One Capital Management, LP

SR One Capital Management, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 11 holding rows worth $498,734,988.

Accession
0000950123-24-011277
Filed
2024-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2024

A holdings report, 11 entries on the cover page, a total value of $498,734,988 stated on the cover page (in dollars after the unit check, H1), rows summing to $498,734,988 with VALUE read as dollars as filed, 13F file number 028-21964. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCELLX INC COMMON STOCK03940C100Stock2,346,630$195,967,071dollars as filed
ZENAS BIOPHARMA INC COM98937L105Stock4,911,539$83,103,240dollars as filed
ARS PHARMACEUTICALS INC82835W108COM4,012,903$58,187,094dollars as filed
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock1,048,951$49,279,718dollars as filed
DESIGN THERAPEUTICS INC25056L103COM6,526,476$35,112,441dollars as filed
MINERALYS THERAPEUTICS INC603170101COM2,016,822$24,423,714dollars as filed
ALUMIS INC022307102COM1,959,896$20,931,689dollars as filed
NKARTA INC65487U108COMMON STOCK3,333,333$15,066,665dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock375,330$9,199,338dollars as filed
ENGENE HOLDINGS INC29286M105COM747,750$4,935,150dollars as filed
KALA BIO INC483119202COM NEW443,661$2,528,868dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-24-011277this filing2024-11-13acceptance time not in the bulk data set